42,700 Shares in Bath & Body Works, Inc. (NYSE:BBWI) Bought by New Mexico Educational Retirement Board

New Mexico Educational Retirement Board purchased a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 42,700 shares of the company's stock, valued at approximately $1,295,000.

Several other institutional investors have also modified their holdings of BBWI. Northwest Bank & Trust Co grew its position in Bath & Body Works by 2.9% in the 4th quarter. Northwest Bank & Trust Co now owns 14,700 shares of the company's stock valued at $533,000 after acquiring an additional 419 shares in the last quarter. Nicolet Bankshares Inc. grew its position in Bath & Body Works by 2.8% in the 4th quarter. Nicolet Bankshares Inc. now owns 17,232 shares of the company's stock valued at $668,000 after acquiring an additional 463 shares in the last quarter. Blue Trust Inc. increased its stake in shares of Bath & Body Works by 15.5% during the first quarter. Blue Trust Inc. now owns 4,184 shares of the company's stock worth $127,000 after buying an additional 560 shares during the period. WINTON GROUP Ltd lifted its stake in Bath & Body Works by 1.6% in the fourth quarter. WINTON GROUP Ltd now owns 36,384 shares of the company's stock worth $1,411,000 after acquiring an additional 577 shares during the last quarter. Finally, TD Private Client Wealth LLC grew its holdings in Bath & Body Works by 34.9% during the 4th quarter. TD Private Client Wealth LLC now owns 2,290 shares of the company's stock worth $89,000 after acquiring an additional 593 shares in the last quarter. Hedge funds and other institutional investors own 95.14% of the company's stock.

Bath & Body Works Price Performance

NYSE BBWI traded down $0.92 on Monday, hitting $31.92. 5,253,373 shares of the company's stock were exchanged, compared to its average volume of 5,247,968. The firm's 50-day moving average price is $30.08 and its two-hundred day moving average price is $32.46. Bath & Body Works, Inc. has a fifty-two week low of $24.94 and a fifty-two week high of $41.87. The firm has a market cap of $6.75 billion, a price-to-earnings ratio of 8.51, a P/E/G ratio of 1.10 and a beta of 1.72.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings results on Thursday, May 29th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.47 by $0.02. The business had revenue of $1.40 billion for the quarter, compared to analyst estimates of $1.42 billion. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%. The company's quarterly revenue was up 2.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.38 EPS. On average, research analysts predict that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, June 20th. Investors of record on Friday, June 6th were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 2.51%. The ex-dividend date of this dividend was Friday, June 6th. Bath & Body Works's payout ratio is currently 21.33%.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on BBWI. Raymond James Financial lowered their target price on shares of Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating for the company in a research note on Thursday, April 17th. UBS Group raised their price target on Bath & Body Works from $32.00 to $36.00 and gave the company a "neutral" rating in a research note on Tuesday, May 20th. Telsey Advisory Group restated an "outperform" rating and issued a $38.00 price target (down from $43.00) on shares of Bath & Body Works in a research note on Thursday, May 29th. JPMorgan Chase & Co. raised their price target on Bath & Body Works from $41.00 to $43.00 and gave the company an "overweight" rating in a research note on Monday, May 19th. Finally, Citigroup raised their price target on Bath & Body Works from $36.00 to $42.00 and gave the company a "buy" rating in a research note on Tuesday, May 20th. Four equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $42.00.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.